InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Browse the detailed record of transactions filed by Gerber Hans-Peter. Director active across 1 company, notably Sutro Biopharma, INC.. Aggregated, 2 filings have been published. Activity tracked since 18 September 2024. The latest transaction was filed on 1 March 2025 (Levée d'options). Regulator: SEC (Form 4). All data is openly available.
2 of 2 declarations